Y-Intercept (HK)’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-9
Closed -$13K 958
2022
Q2
$13K Buy
+9
New +$13K ﹤0.01% 802